Mary Dwight
Showing 1–2 of 2 transcripts.
- Milken Institute1h 2m
If You Cure It, Will They Pay? Placing a Value on Lives
Mary Dwight, Reed Tuckson, Dean Rosen, Greg Alton
A healthcare sector conference examined the critical clash between high-cost breakthrough therapies like Kalydeco and Sovaldi and a reimbursement system ill-equipped to manage upfront expenses for long-term savings. Industry leaders, including representatives from Gilead Sciences and payer organizations, discussed a decisive shift toward value-based models where commercial viability now depends on real-world data proving total cost of care reduction. The event highlighted emerging trends in collaborative guidelines and investment strategies that prioritize cost-effective innovation and shared risk structures to prevent system-wide financial attrition.
- Milken Institute1h 4m
Big Data for Better Cures: Where to Invest?
Cecilia Arradaza, Marty Cohn, Joel Dudley, Magali Haas, Risa Sack, Andy von Eschenbach, Harlan Weissman, Garrett, Mary Dwight
Leading healthcare experts including Marty Cohn, Joel Dudley, and Andy von Eschenbach converged to identify that while big data offers potential to reduce waste and personalize care, its adoption is currently stifled by incentive misalignment, fragmented data silos, and a regulatory framework built on pre-market rather than post-market surveillance. The panel consensus highlighted that shifting from fee-for-service to value-based care and establishing a "model of the normal" human are critical prerequisites for unlocking predictive analytics in chronic disease and neurology. To advance these goals, the speakers urged the creation of broad consent models, common data standards for cross-organizational sharing, and new reimbursement structures that specifically reward data utility over collection.